SCHEMBL3030947

SCHEMBL3030947

C=CCON=Cc1ccc(-c2ccccc2NC(=O)c2sc(C)nc2C(F)F)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
ALDH1A1 P00352 7/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
POLB P06746 2/20 0.34
HTT P42858 2/20 0.34
USP2 O75604 1/20 0.34
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
RAB9A P51151 3/20 0.32
RECQL P46063 1/20 0.32
KDM4E B2RXH2 3/20 0.32
LMNA P02545 2/20 0.32
NPC1 O15118 2/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3030942 1.00 MAPT (0.35) MAPTALDH1A1TSHRHSD17B10POLB
SCHEMBL13215931 1.00 MAPT (0.35) MAPTALDH1A1TSHRHSD17B10POLB
SCHEMBL14578315 0.88 ALDH1A1 (0.39) MAPTALDH1A1TSHRHSD17B10POLB
SCHEMBL6255403 0.87 MAPT (0.33) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL13215935 0.87 CHRM3 (0.36) MAPTALDH1A1TSHRHSD17B10POLB
SCHEMBL13215992 0.87 MAPT (0.35) MAPTALDH1A1TSHRHSD17B10POLB
SCHEMBL13215927 0.86 HTT (0.40) MAPTALDH1A1TSHRHSD17B10POLB
SCHEMBL13064249 0.80 TSHR (0.50) MAPTALDH1A1TSHRHSD17B10POLB
SCHEMBL4790540 0.80 IRAK4 (0.37) MAPTALDH1A1HTTKDM4ELMNA
SCHEMBL4790543 0.80 IRAK4 (0.37) MAPTALDH1A1HTTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216849-A1 BIPHENYLCARBOXAMIDES DUNKEL RALF 2010-08-26 US disclosed
US-7728019-B2 Biphenylcarboxamides BAYER CROPSCIENCE AG (DE) 2010-06-01 US disclosed
US-20080085924-A1 Biphenylcaboxamides BAYER CROPSCINCE AG (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085924-A1 Biphenylcaboxamides AHR, Q6ZSR9, DDT MAPT 3566/4885ALDH1A1 415/4885TSHR 3138/4885
US-20100216849-A1 BIPHENYLCARBOXAMIDES AHR, DDT, MRPL21 MAPT 3801/4885ALDH1A1 478/4885TSHR 3209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.